370 likes | 1.58k Views
Artemisinin. BLI Research Project By: Tiffany Hou. Introduction. Malaria affects hundreds of thousands of people each year in the tropics and sub tropics Many anti-malarial drugs have developed resistance ACTs are the best form of treatment, but is largely unaffordable
E N D
Artemisinin BLI Research Project By: Tiffany Hou
Introduction • Malaria affects hundreds of thousands of people each year in the tropics and sub tropics • Many anti-malarial drugs have developed resistance • ACTs are the best form of treatment, but is largely unaffordable • Scientists are trying to use synthetic biology to produce ACTs
Malaria • About half of the world is at risk for malaria • 219 million people are infected with malaria every year and 660,000 die from it
Artemisinin • Powerful anti-malarial drug • Derived from Artemisia annua (A. annua) • Grows in China and Vietnam • First synthesized in 1979 by Chinese scientists • Artemisinin is part of the isoprenoid family, which are organic compounds composed of two or more units of hydrocarbons
How Does Artemisinin Work? • Reduces parasite’s biomass • Attacks the parasite’s sexual stage of life cycle • Main chemical feature is the unstable bond between two oxygen atoms which allows it to produce free radicals that break up proteins in the protozoa • The release occurs upon exposure to Hemozoin
Problems and Limitations of Artemisinin • Cost • Poor cure rate of monotherapy • Neurotoxicity
Cost • Artemisinin has presented a supply chain challenge in the pharmaceutical industry • The demand has outstripped the supply and the shortages have caused the prices to soar • A dose of Artemisinin costs $1.30 whereas another anti-malarial drug, chloroquine, costs $0.25 per dose
Poor Cure Rate of Monotherapy • Modeling studies suggests 6 days of treatment, but high rates of recrudescence do not match up with the model • High rates are usually attributed to the short half life of artemisinin and the increased drug clearance caused by repeated dosage • Pharmacokinetic behavior is not the only problem
Neurotoxicity • Artemisinin has been show to cause brainstem toxicity in animals in pre-clinical experiments • Millions of doses in various formulations have been given to humans and none of them show signs of major neurotoxicity • Probable cause of neurotoxicity is the duration of exposure rather than maximum concentrations • There has been a recent claim that artemisinin causes mild but significant hearing loss • Concern of neurotoxicity should be maintained in children who have a more vulnerable neurological system and have limited therapeutic experience
The Heroes • Jay Keasling • Amyris and Sanofi • World Health Organization
Derivatives and ACTs • Artemisinin derivatives are semi-synthetic artemisinin based compounds that improve the effectiveness of artemisinin • ACTs are Artemisinin-based Combination Therapy treatments which are made from fast acting artemisinin based compounds and drugs from a different class • Benefits of ACTs are their high efficacy, fast action, and the reduced likelihood of resistance formation
How Does Microbial Production ofArtemisinin Solve the Problem? • Cost is lowered because extracting artemisinin from the plant is much more difficult and time consuming • Access of the technology to produce synthetic artemisinin can be restricted to responsible manufacturers who will only manufacture and sell ACTs • Not much is known about the link between artemisinin and neurotoxicity, but artemisinin derivatives have less major toxicity than other available anti-malarial drugs
Other Benefits • Synthetic artemisinin is anticipated to have an impact on the pervasiveness of counterfeit drugs
Work Cited • http://www.path.org/projects/artemisinin.php • http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12051.html • http://www.eurekalert.org/pub_releases/2013-04/uoc--los040913.php • http://factsanddetails.com/world.php?itemid=2143&catid=57&subcatid=381 • http://www.nature.com/scitable/blog/bio2.0/artemisinin_a_synthetic_biology_success • http://www.ncbi.nlm.nih.gov/books/NBK1717/ • http://malaria.wellcome.ac.uk/doc_WTD023879.html • http://www.abpischools.org.uk/res/coresourceimport/resources04/diseases/disease9.cfm • http://www.rice.edu/~jenky/sports/antiox.html • http://en.wikipedia.org/wiki/Hemozoin • http://pmj.bmj.com/content/81/952/71.full.pdf • http://www.amyris.com/Products/176/Artemisinin • http://today.lbl.gov/2013/04/12/large-scale-production-of-antimalaria-drug-artemisinin-begins/ • http://www.malariaconsortium.org/pages/112.htm • http://www.medindia.net/health-infographics/images/malaria-drug-resistance.jpg • http://www.smeds.org/7th%20Malaria/Peterson/places%20affected%20by%20malaria.gif • http://www.lymenatuurlijkgenezen.nl/images/artemisia_annua.jpg • http://factsanddetails.com/media/2/20120531-628px-Artemisinin_1.png • http://today.lbl.gov/wordpress/wp-content/uploads/keaslingandkids.jpg • http://www.ncbi.nlm.nih.gov/books/NBK1717/bin/198f2.jpg • http://www.nature.com/nature/journal/vaop/ncurrent/images/nature12051-f1.2.jpg